Position
Chief Executive Officer
Company
Childhood Arthritis and Rheumatology Research Alliance
WashingtonBiotechnologyHealth CareNon ProfitDescription
The Childhood Arthritis and Rheumatology Research Alliance (CARRA) has appointed Rachel Myslinski as its Chief Executive Officer. Myslinski brings over 20 years of experience in healthcare and has an extensive background in strategic planning and financial management.
Quick answer
CARRA Appoints Rachel Myslinski as Chief Executive Officer (June 4, 2025). Childhood Arthritis and Rheumatology Research Alliance is based in Washington, District Of Columbia, United States.
- Who is the new Chief Executive Officer at Childhood Arthritis and Rheumatology Research Alliance?
- Childhood Arthritis and Rheumatology Research Alliance named Rachel Myslinski Chief Executive Officer, announced June 4, 2025.
- What did Childhood Arthritis and Rheumatology Research Alliance announce on June 4, 2025?
- The Childhood Arthritis and Rheumatology Research Alliance (CARRA) has appointed Rachel Myslinski as its Chief Executive Officer. Myslinski brings over 20 years of experience in healthcare and has an extensive background in strategic planning and financial management.
- What does Childhood Arthritis and Rheumatology Research Alliance do?
- The Childhood Arthritis and Rheumatology Research Alliance (CARRA) is a 501(c)3 registered non-profit organization.
- Where is Childhood Arthritis and Rheumatology Research Alliance based?
- Childhood Arthritis and Rheumatology Research Alliance is based in Washington, District Of Columbia, United States.
- Which similar companies made leadership changes around the same time?
- Cure Rare Disease (June 9, 2025), American Oncology Network (May 13, 2025), United Wholesale Mortgage (July 2, 2025) and Civica (July 14, 2025) also announced leadership changes within 45 days of Childhood Arthritis and Rheumatology Research Alliance.
Source: Fundz verified event record.
Other recent leadership changes in Non Profit and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cure Rare Disease Appoints Keith Sutton as Chief Science Officer (June 9, 2025)
- American Oncology Network Appoints Terri Casey as Chief Human Resources Officer (May 13, 2025)
- United Wholesale Mortgage Appoints Allen Beydoun as Chief Client Officer (July 2, 2025)
- Civica Appoints Dave Sehgal, Ph.D. as Chief Manufacturing Officer and Supply Chain Officer (July 14, 2025)
- Reframe Cancer Appoints Professor Ben Kelly as Chief Operating Officer (April 24, 2025)
- Lotus Therapeutics Appoints Leslie Felix as Chief Growth Officer (June 4, 2025)
Who to call at Childhood Arthritis and Rheumatology Research Alliance, and when
A new leader at Childhood Arthritis and Rheumatology Research Alliance brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Childhood Arthritis and Rheumatology Research Alliance raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Childhood Arthritis and Rheumatology Research Alliance, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Childhood Arthritis and Rheumatology Research Alliance. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Childhood Arthritis and Rheumatology Research Alliance changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Childhood Arthritis and Rheumatology Research Alliance changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.